Extensive preclinical research shows it influences collagen synthesis, antioxidant defense, and tissue regeneration in cell and animal models
In vitro experiments confirmed that somaluride did not inhibit or induce CYP enzymes, nor did it interact with drug transporters
But the most important metrics for employers are: Clinical outcomes % weight loss at 3, 6, 12 months Improvements in blood pressure, HbA1c, cholesterol (where available) Medication usage trends Average GLP-1 dose per member Time on medication Escalation and tapering rates Behavior change engagement Weekly coaching session attendance Improvements in sleep, nutrition, movement, stress Financial impact Changes in obesity-related claims (e.g
Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis
Then revisit GLP-1 treatment when you have a clear baseline